NMIMC
AGIO icon

Northwestern Mutual Investment Management Company’s Agios Pharmaceuticals AGIO Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,050
Closed -$198K – 909
2015
Q4 		$198K Buy
3,050
+10
+0.3% +$656 ﹤0.01% 715
2015
Q3 		$215K Hold
3,040
– – ﹤0.01% 714
2015
Q2 		$338K Buy
+3,040
New +$327K 0.01% 683

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FVF2
Flagship Ventures Fund 2007 Cambridge, Massachusetts $95.2M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northwestern Mutual Investment Management Company's AGIO Position: Q1 2016 in Review

Northwestern Mutual Investment Management Company sold out of Agios Pharmaceuticals (AGIO) in Q1 2016, closing a stake of 3,050 shares — an estimated $198K sold.

Northwestern Mutual Investment Management Company first reported a position in AGIO in Q2 2015 and held it in 3 quarters. The position peaked at $338K in Q2 2015. 157 funds tracked by Wall St. Rank hold AGIO as of Q1 2016.

  • Northwestern Mutual Investment Management Company reported no remaining Agios Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Northwestern Mutual Investment Management Company sold 3,050 Agios Pharmaceuticals shares in Q1 2016, an estimated $198K.
  • Northwestern Mutual Investment Management Company first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Northwestern Mutual Investment Management Company's Agios Pharmaceuticals position peaked at $338K in Q2 2015.
  • 157 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2016, filed 16 May 2016.